Salivary Gland Infection Global Market Report 2025

Salivary Gland Infection Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on salivary gland infection market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.
Description:

Where is the largest and fastest growing market for salivary gland infection ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The salivary gland infection market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:
  • The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.
  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope

Markets Covered:1) By Diagnosis: Plain Radiography; Sialography; Computed Tomography (CT); Magnetic Resonance Imaging (MRI); Radionuclide Scintigraphy; High-resolution Ultrasonography; Other Diagnoses

2) By Treatment: Medications; Surgery; Aspiration; Home Care; Other Treatments

3) By End User: Hospitals And Clinics; Medical Research Centers; Academic Institutes; Other End User

Subsegments:

1) By Plain Radiography: X-ray Of Salivary Glands; Sialography With X-ray

2) By Sialography: Conventional Sialography; Digital Subtraction Sialography (DSS)

3) By Computed Tomography (CT): Non-contrast CT; Contrast-enhanced CT

4) By Magnetic Resonance Imaging (MRI): MRI without contrast; MRI With contrast (Dynamic MRI)

5) By Radionuclide Scintigraphy: Planar Scintigraphy; SPECT (Single Photon Emission Computed Tomography)

6) By High-resolution Ultrasonography: Standard Ultrasonography; Doppler Ultrasonography

7) By Other Diagnoses: Fine Needle Aspiration (FNA) Biopsy; Endoscopy; Salivary Flow Test

Companies Mentioned: Pfizer Inc.; Johnson & Johnson; Roche Holding AG; Merck & Co. Inc.; AbbVie Inc.

Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain

Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa

Time series: Five years historic and ten years forecast.

Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,

Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.

Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

Delivery format: PDF, Word and Excel Data Dashboard.

Please Note: Report will be updated with the latest data and delivered to you within 3-5 working days of order.


1. Executive Summary
2. Salivary Gland Infection Market Characteristics
3. Salivary Gland Infection Market Trends And Strategies
4. Salivary Gland Infection Market - Macro Economic Scenario Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market
5. Global Salivary Gland Infection Growth Analysis And Strategic Analysis Framework
5.1. Global Salivary Gland Infection PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global Salivary Gland Infection Market Growth Rate Analysis
5.4. Global Salivary Gland Infection Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global Salivary Gland Infection Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global Salivary Gland Infection Total Addressable Market (TAM)
6. Salivary Gland Infection Market Segmentation
6.1. Global Salivary Gland Infection Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Plain Radiography
Sialography
Computed Tomography (CT)
Magnetic Resonance Imaging (MRI)
Radionuclide Scintigraphy
High-resolution Ultrasonography
Others Diagnosis
6.2. Global Salivary Gland Infection Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Medications
Surgery
Aspiration
Home Care
Other Treatments
6.3. Global Salivary Gland Infection Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Hospitals And Clinics
Medical Research Centers
Academic Institutes
Other End User
6.4. Global Salivary Gland Infection Market, Sub-Segmentation Of Plain Radiography, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
X-ray Of Salivary Glands
Sialography With X-ray
6.5. Global Salivary Gland Infection Market, Sub-Segmentation Of Sialography, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Conventional Sialography
Digital Subtraction Sialography (DSS)
6.6. Global Salivary Gland Infection Market, Sub-Segmentation Of Computed Tomography (CT), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Non-contrast CT
Contrast-enhanced CT
6.7. Global Salivary Gland Infection Market, Sub-Segmentation Of Magnetic Resonance Imaging (MRI), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
MRI without contrast
MRI With contrast (Dynamic MRI)
6.8. Global Salivary Gland Infection Market, Sub-Segmentation Of Radionuclide Scintigraphy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Planar Scintigraphy
SPECT (Single Photon Emission Computed Tomography)
6.9. Global Salivary Gland Infection Market, Sub-Segmentation Of High-resolution Ultrasonography, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Standard Ultrasonography
Doppler Ultrasonography
6.10. Global Salivary Gland Infection Market, Sub-Segmentation Of Other Diagnoses, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Fine Needle Aspiration (FNA) Biopsy
Endoscopy
Salivary Flow Test
7. Salivary Gland Infection Market Regional And Country Analysis
7.1. Global Salivary Gland Infection Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
7.2. Global Salivary Gland Infection Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8. Asia-Pacific Salivary Gland Infection Market
8.1. Asia-Pacific Salivary Gland Infection Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Salivary Gland Infection Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.3. Asia-Pacific Salivary Gland Infection Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.4. Asia-Pacific Salivary Gland Infection Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
9. China Salivary Gland Infection Market
9.1. China Salivary Gland Infection Market Overview
9.2. China Salivary Gland Infection Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.3. China Salivary Gland Infection Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.4. China Salivary Gland Infection Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
10. India Salivary Gland Infection Market
10.1. India Salivary Gland Infection Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.2. India Salivary Gland Infection Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.3. India Salivary Gland Infection Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11. Japan Salivary Gland Infection Market
11.1. Japan Salivary Gland Infection Market Overview
11.2. Japan Salivary Gland Infection Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.3. Japan Salivary Gland Infection Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.4. Japan Salivary Gland Infection Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12. Australia Salivary Gland Infection Market
12.1. Australia Salivary Gland Infection Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.2. Australia Salivary Gland Infection Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.3. Australia Salivary Gland Infection Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13. Indonesia Salivary Gland Infection Market
13.1. Indonesia Salivary Gland Infection Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.2. Indonesia Salivary Gland Infection Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.3. Indonesia Salivary Gland Infection Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14. South Korea Salivary Gland Infection Market
14.1. South Korea Salivary Gland Infection Market Overview
14.2. South Korea Salivary Gland Infection Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.3. South Korea Salivary Gland Infection Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.4. South Korea Salivary Gland Infection Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15. Western Europe Salivary Gland Infection Market
15.1. Western Europe Salivary Gland Infection Market Overview
15.2. Western Europe Salivary Gland Infection Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.3. Western Europe Salivary Gland Infection Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.4. Western Europe Salivary Gland Infection Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16. UK Salivary Gland Infection Market
16.1. UK Salivary Gland Infection Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.2. UK Salivary Gland Infection Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.3. UK Salivary Gland Infection Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17. Germany Salivary Gland Infection Market
17.1. Germany Salivary Gland Infection Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.2. Germany Salivary Gland Infection Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.3. Germany Salivary Gland Infection Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18. France Salivary Gland Infection Market
18.1. France Salivary Gland Infection Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.2. France Salivary Gland Infection Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.3. France Salivary Gland Infection Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19. Italy Salivary Gland Infection Market
19.1. Italy Salivary Gland Infection Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.2. Italy Salivary Gland Infection Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.3. Italy Salivary Gland Infection Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20. Spain Salivary Gland Infection Market
20.1. Spain Salivary Gland Infection Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.2. Spain Salivary Gland Infection Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.3. Spain Salivary Gland Infection Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21. Eastern Europe Salivary Gland Infection Market
21.1. Eastern Europe Salivary Gland Infection Market Overview
21.2. Eastern Europe Salivary Gland Infection Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.3. Eastern Europe Salivary Gland Infection Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.4. Eastern Europe Salivary Gland Infection Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22. Russia Salivary Gland Infection Market
22.1. Russia Salivary Gland Infection Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.2. Russia Salivary Gland Infection Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.3. Russia Salivary Gland Infection Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23. North America Salivary Gland Infection Market
23.1. North America Salivary Gland Infection Market Overview
23.2. North America Salivary Gland Infection Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.3. North America Salivary Gland Infection Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.4. North America Salivary Gland Infection Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24. USA Salivary Gland Infection Market
24.1. USA Salivary Gland Infection Market Overview
24.2. USA Salivary Gland Infection Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.3. USA Salivary Gland Infection Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.4. USA Salivary Gland Infection Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25. Canada Salivary Gland Infection Market
25.1. Canada Salivary Gland Infection Market Overview
25.2. Canada Salivary Gland Infection Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.3. Canada Salivary Gland Infection Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.4. Canada Salivary Gland Infection Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26. South America Salivary Gland Infection Market
26.1. South America Salivary Gland Infection Market Overview
26.2. South America Salivary Gland Infection Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.3. South America Salivary Gland Infection Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.4. South America Salivary Gland Infection Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27. Brazil Salivary Gland Infection Market
27.1. Brazil Salivary Gland Infection Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.2. Brazil Salivary Gland Infection Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.3. Brazil Salivary Gland Infection Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28. Middle East Salivary Gland Infection Market
28.1. Middle East Salivary Gland Infection Market Overview
28.2. Middle East Salivary Gland Infection Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.3. Middle East Salivary Gland Infection Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.4. Middle East Salivary Gland Infection Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29. Africa Salivary Gland Infection Market
29.1. Africa Salivary Gland Infection Market Overview
29.2. Africa Salivary Gland Infection Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.3. Africa Salivary Gland Infection Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.4. Africa Salivary Gland Infection Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
30. Salivary Gland Infection Market Competitive Landscape And Company Profiles
30.1. Salivary Gland Infection Market Competitive Landscape
30.2. Salivary Gland Infection Market Company Profiles
30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
30.2.2. Johnson & Johnson Overview, Products and Services, Strategy and Financial Analysis
30.2.3. Roche Holding AG Overview, Products and Services, Strategy and Financial Analysis
30.2.4. Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
30.2.5. AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis
31. Salivary Gland Infection Market Other Major And Innovative Companies
31.1. AstraZeneca plc
31.2. Novartis AG
31.3. GSK plc
31.4. Eli Lilly and Company
31.5. Gilead Sciences, Inc.
31.6. Amgen Inc.
31.7. FUJIFILM Holdings Corporation
31.8. Teva Pharmaceutical Industries Ltd.
31.9. Boehringer Ingelheim GmbH
31.10. Astellas Pharma Inc.
31.11. Sandoz International GmbH
31.12. Vertex Pharmaceuticals Incorporated
31.13. Incyte Corporation.
31.14. Hikma Pharmaceuticals PLC
31.15. Lupin Pharmaceuticals, Inc.
32. Global Salivary Gland Infection Market Competitive Benchmarking And Dashboard
33. Key Mergers And Acquisitions In The Salivary Gland Infection Market
34. Recent Developments In The Salivary Gland Infection Market
35. Salivary Gland Infection Market High Potential Countries, Segments and Strategies
35.1 Salivary Gland Infection Market In 2029 - Countries Offering Most New Opportunities
35.2 Salivary Gland Infection Market In 2029 - Segments Offering Most New Opportunities
35.3 Salivary Gland Infection Market In 2029 - Growth Strategies
35.3.1 Market Trend Based Strategies
35.3.2 Competitor Strategies
36. Appendix
36.1. Abbreviations
36.2. Currencies
36.3. Historic And Forecast Inflation Rates
36.4. Research Inquiries
36.5. The Business Research Company
36.6. Copyright And Disclaimer

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings